October 4, 2013 — Theragenics Corporation announced it has signed a supply and reseller agreement with Accelyon Limited. Under the three-year agreement, Theragenics will supply its AgX100 seeds to Accelyon, who will provide for the loading and packaging of the seeds into prescription loaded needles, custom strands and other configurations. Accelyon will distribute the finished products in the European Union, Australia and New Zealand.
“This agreement is our first major opportunity to penetrate Europe, Australia and New Zealand with our brachytherapy seed product,” said M. Christine Jacobs, chairman and CEO, Theragenics Corporation. “We have expected our AgX100 iodine seed to provide opportunities outside of the United States. Accelyon provides us this access in these important brachytherapy markets. They have international expertise and reach we do not possess.”
For more information: www.theragenics.com
April 25, 2024 
